Metraipolis › archive › dc_f493fda51941

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis — Europe PMC PMID:41134303

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41134303
DOI
10.14309/ctg.0000000000000931
License (as archived)
solo-consultazione
Archived
2026-11-07T06:29:24.440Z
SHA-256 of the archived text
5d3b3ff60ba367a89a3976943476ab81271e4968529fa0272e16b04026be2958
Stable URL of this page
https://metraipolis.com/documento/dc_f493fda51941

How to cite

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis — Europe PMC PMID:41134303 — Europe PMC (en), https://europepmc.org/article/MED/41134303 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f493fda51941 (Metraipolis archive dc_f493fda51941, sha256 5d3b3ff60ba367a89a3976943476ab81271e4968529fa0272e16b04026be2958)
BibTeX
@misc{dcf493fda51941,
  title = {Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis — Europe PMC PMID:41134303},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41134303},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f493fda51941; sha256 5d3b3ff60ba367a89a3976943476ab81271e4968529fa0272e16b04026be2958},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41134303. Agents can read the archived copy with the MCP tool read_document.